Min Zheng, Haifeng Gu, Jian Zhou, Jianwei Wang, LiLi Liu, Yun Zhou, Baoyue Pan, Qingna Chen, Huijuan He, Weijun Ye, Yan Ding, Li Zhou, Li Sun, Mingyi Li, Xinping Cao, Jin-Xin Bei. "Efficacy and safety of cadonilimab (CD) in combination with disitamab vedotin (RC48) or nab-paclitaxel (NP) in the treatment of recurrent or metastatic cervical cancer (r/mCC): A prospective, double-cohort, multicenter, open-label, phase II clinical study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.5526